Increased presence of FOXP3+ regulatory T cells in inflamed muscle of patients with active juvenile dermatomyositis compared to peripheral blood

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Vercoulen, Yvonne ^a,f   Bellutti Enders, Felicitas ^a,b   Meerding, Jenny ^a   Plantinga, Maud ^a   Elst, Elisabeth F ^a   Varsani, Hemlata ^c   Van Schieveen, Christa ^a   Bakker, Mette H ^a   Klein, Mark ^a   Scholman, Rianne C ^a   Spliet, Wim ^d   Ricotti, Valeria ^c   Koenen, Hans J P M ^e   De Weger, Roel A ^d   Wedderburn, Lucy R ^c   Van Royen Kerkhof, Annet ^a   Prakken, Berent J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN; METHOTREXATE; PREDNISONE; TRANSCRIPTION FACTOR FOXP3; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN;

ADOLESCENT; ARTICLE; CELL ASSAY; CELLULAR DISTRIBUTION; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE CONTROL; DRUG MEGADOSE; DUCHENNE MUSCULAR DYSTROPHY; FEMALE; FLOW CYTOMETRY; FOXP3+ REGULATORY T LYMPHOCYTE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; JUVENILE DERMATOMYOSITIS; LOW DRUG DOSE; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; MUSCLE BIOPSY; ONSET AGE; PERIPHERAL BLOOD MONONUCLEAR CELL; PERIPHERAL LYMPHOCYTE; PHENOTYPE; PRESCHOOL CHILD; REGULATORY T LYMPHOCYTE; REMISSION; SCHOOL CHILD; BLOOD; DERMATOMYOSITIS; IMMUNOLOGY; INFANT; MUSCLE; PATHOLOGY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DERMATOMYOSITIS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INFANT; MALE; MUSCLES; T-LYMPHOCYTES, REGULATORY;

EID: 84921670783     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105353     Document Type: Article

References (31)

1. Mendez EP, Lipton R, Ramsey-Goldman R, Roettcher P, Bowyer S, et al. (2003) US incidence of juvenile dermatomyositis, 1995-1998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry. Arthritis Rheum 49: 300-305. (Pubitemid 36682395)
2. De Paepe B, Creus KK, De Bleecker JL (2009) Role of cytokines and chemokines in idiopathic inflammatory myopathies. Curr Opin Rheumatol 21: 610-616.
3. Bellutti Enders F, van Wijk F, Scholman R, Hofer M, Prakken BJ, et al. (2014) CXCL10, TNFR2 and Galectin-9 correlate with disease activity in Juvenile Dermatomyositis. Arthritis Rheumatol.
4. Nistala K, Varsani H, Wittkowski H, Vogl T, Krol P, et al. (2013) Myeloid related protein induces muscle derived inflammatory mediators in juvenile dermatomyositis. Arthritis Res Ther 15: R131.
5. Reed AM, Peterson E, Bilgic H, Ytterberg SR, Amin S, et al. (2012) Changes in novel biomarkers of disease activity in juvenile and adult dermatomyositis are sensitive biomarkers of disease course. Arthritis Rheum 64: 4078-4086.
6. McDouall RM, Dunn MJ, Dubowitz V (1990) Nature of the mononuclear infiltrate and the mechanism of muscle damage in juvenile dermatomyositis and Duchenne muscular dystrophy. J Neurol Sci 99: 199-217. (Pubitemid 20387378)
7. Fontenot JD, Gavin MA, Rudensky AY (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4: 330-336. (Pubitemid 36432314)
8. Wehrens EJ, Prakken BJ, van Wijk F (2013) T cells out of control-impaired immune regulation in the inflamed joint. Nat Rev Rheumatol 9: 34-42.
9. de Kleer IM, Wedderburn LR, Taams LS, Patel A, Varsani H, et al. (2004) CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J Immunol 172: 6435-6443. (Pubitemid 38621253)
10. Antiga E, Quaglino P, Bellandi S, Volpi W, Del Bianco E, et al. (2010) Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea. Br J Dermatol 162: 1056-1063.
11. Banica L, Besliu A, Pistol G, Stavaru C, Ionescu R, et al. (2009) Quantification and molecular characterization of regulatory T cells in connective tissue diseases. Autoimmunity 42: 41-49.
12. Waschbisch A, Schwab N, Ruck T, Stenner MP, Wiendl H (2010) FOXP3+ T regulatory cells in idiopathic inflammatory myopathies. J Neuroimmunol 225: 137-142.
13. Deknuydt F, Bioley G, Valmori D, Ayyoub M (2009) IL-1beta and IL-2 convert human Treg into T(H)17 cells. Clin Immunol 131: 298-307.
14. Koenen HJ, Smeets RL, Vink PM, van Rijssen E, Boots AM, et al. (2008) Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood 112: 2340-2352.
15. Voo KS, Wang YH, Santori FR, Boggiano C, Wang YH, et al. (2009) Identification of IL-17-producing FOXP3+ regulatory T cells in humans. Proc Natl Acad Sci U S A 106: 4793-4798.
16. Ayyoub M, Deknuydt F, Raimbaud I, Dousset C, Leveque L, et al. (2009) Human memory FOXP3+ Tregs secrete IL-17 ex vivo and constitutively express the T(H)17 lineage-specific transcription factor RORgamma t. Proc Natl Acad Sci U S A 106: 8635-8640.
17. Pesenacker AM, Bending D, Ursu S, Wu Q, Nistala K, et al. (2013) CD161 defines the subset of FoxP3+ T cells capable of producing proinflammatory cytokines. Blood 121: 2647-2658.
18. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292: 344-347.
19. Ruperto N, Ravelli A, Murray KJ, Lovell DJ, Andersson-Gare B, et al. (2003) Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis. Rheumatology (Oxford) 42: 1452-1459. (Pubitemid 37508918)
20. Bovenschen HJ, van de Kerkhof PC, van Erp PE, Woestenenk R, Joosten I, et al. (2011) Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin. J Invest Dermatol 131: 1853-1860.
21. Nocentini G, Riccardi C (2005) GITR: a multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily. Eur J Immunol 35: 1016-1022. (Pubitemid 40542207)
22. Walker LS (2013) Treg and CTLA-4: two intertwining pathways to immune tolerance. J Autoimmun 45: 49-57.
23. Braitch M, Harikrishnan S, Robins RA, Nichols C, Fahey AJ, et al. (2009) Glucocorticoids increase CD4CD25 cell percentage and Foxp3 expression in patients with multiple sclerosis. Acta Neurol Scand 119: 239-245.
24. Chen X, Oppenheim JJ, Winkler-Pickett RT, Ortaldo JR, Howard OM (2006) Glucocorticoid amplifies IL-2-dependent expansion of functional FoxP3(+)CD4(+)CD25(+) T regulatory cells in vivo and enhances their capacity to suppress EAE. Eur J Immunol 36: 2139-2149. (Pubitemid 44251759)
25. Ruprecht CR, Gattorno M, Ferlito F, Gregorio A, Martini A, et al. (2005) Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia. J Exp Med 201: 1793-1803. (Pubitemid 41002898)
26. Burzyn D, Kuswanto W, Kolodin D, Shadrach JL, Cerletti M, et al. (2013) A special population of regulatory T cells potentiates muscle repair. Cell 155: 1282-1295.
27. Tournadre A, Miossec P (2012) Interleukin-17 in inflammatory myopathies. Curr Rheumatol Rep 14: 252-256.
28. Shen H, Xia L, Lu J, Xiao W (2011) Interleukin-17 and interleukin-23 in patients with polymyositis and dermatomyositis. Scand J Rheumatol 40: 217-220.
29. Haufe S, Haug M, Schepp C, Kuemmerle-Deschner J, Hansmann S, et al. (2011) Impaired suppression of synovial fluid CD4+CD25- T cells from patients with juvenile idiopathic arthritis by CD4+CD25+ Treg cells. Arthritis Rheum 63: 3153-3162.
30. Wehrens EJ, Mijnheer G, Duurland CL, Klein M, Meerding J, et al. (2011) Functional human regulatory T cells fail to control autoimmune inflammation due to PKB/c-akt hyperactivation in effector cells. Blood 118: 3538-3548.
31. Spencer CH, Hanson V, Singsen BH, Bernstein BH, Kornreich HK, et al. (1984) Course of treated juvenile dermatomyositis. J Pediatr 105: 399-408. (Pubitemid 14072122)